SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (APGE) (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback